Antabuse repurposing: We need more knowledge and wide international support

International Journal of Cancer

Volumn 129, Issue 5, 2011, Pages 1286-1287

  Cvek, Boris ^a,b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b Slechtitelu 11   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; COPPER; DISULFIRAM;

ANTINEOPLASTIC ACTIVITY; COST EFFECTIVENESS ANALYSIS; DRUG RESEARCH; FUNDING; HUMAN; LETTER; MEDICAL SOCIETY; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; PUBLICATION;

EID: 79959709444     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25779     Document Type: Letter

References (8)

1. Johansson B,. A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr Scand Suppl 1992; 369: 15-26.
2. Thorn GD, Ludwig RA,. The dithiocarbamates and related compounds. Amsterdam: Elsevier Publishing Company, 1962. 298 p.
3. Cvek B, Cvorak Z,. Targeting of nuclear factor-κB and proteasome by dithiocarbamate complexes with metals. Curr Pharm Des 2007; 13: 3155-3167. (Pubitemid 350138963)
4. Brar SS, Grigg C, Wilson KS, Holder WD, Dreau D, Austin C, Foster M, Ghio AJ, Whorton AR, Stowell GW, Whittall LB, Whittle RR, et al. Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease. Mol Cancer Ther 2004; 3: 1049-1060. (Pubitemid 39295002)
5. Chen D, Cui QC, Yang H, Dou QP,. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res 2006; 66: 10425-10433. (Pubitemid 44799763)
6. Cvek B, Milacic V, Taraba J, Dou QP,. Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells. J Med Chem 2008; 51: 6256-6258.
7. Cressey D,. Health economics: life in the balance. Nature 2009; 461: 336-339.
8. Moran M,. A breakthrough in R&D for neglected diseases: new ways to get the drugs we need. PLoS Med 2005; 2: e302.